Guillain-Barre syndrome: background incidence rates in The Netherlands

被引:14
|
作者
van der Maas, Nicoline A. T. [1 ,2 ,3 ]
Kramer, Merlijn A. [1 ]
Jacobs, Bart C. [2 ,3 ]
van Soest, Eva M. [4 ]
Dieleman, Jeanne P. [4 ]
Kemmeren, Jeanet M. [1 ]
de Melker, Hester E. [1 ]
Sturkenboom, Miriam C. J. M. [5 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands
[2] Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands
[3] Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands
[4] Univ Med Ctr, Dept Med Informat, Rotterdam, Netherlands
[5] Univ Med Ctr, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
关键词
Guillain-Barre syndrome; incidence rate; vaccination; PATIENT RECORDS; IMMUNIZATION; SURVEILLANCE; FEATURES;
D O I
10.1111/j.1529-8027.2011.00356.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Guillain-Barre syndrome (GBS) is a (sub) acute polyradiculoneuropathy, which may occur following immunization. To interpret the occurrence of GBS after introduction of large-scale immunization programmes, it is important to define recent background incidence rates (IRs) of GBS. We used a general practitioner electronic medical record database to assess age-specific GBS IRs between 1996 and 2008 in The Netherlands. All possible GBS cases were manually reviewed. Validated incident cases were reviewed by a neurologist (B. J.) for diagnostic certainty using the GBS case definition of the Brighton Collaboration (BC). In a population of 638,891 persons, we identified 23 validated incident GBS cases (mean age 46 years). IR was 1.14 per 100,000 person years (95% confidence interval [CI] 0.67-1.61) and was lower for people under 50 years (0.76; 95% CI 0.41-1.32) compared with elderly of 50 years or older (1.80; 95% CI 0.98-3.05). Only six cases fulfilled level 1 or 2 of diagnostic certainty of the BC case definition. IR of GBS increases with age. As vaccinations are often targeted at specific age groups, age-specific rates should be used to monitor GBS observed versus expected rates after introduction of large-scale vaccination programmes.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [41] Pain in Guillain-Barre syndrome
    Umapathi, Thirugnanam
    Yuki, Nobuhiro
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (03) : 335 - 339
  • [42] Management of Guillain-Barre Syndrome
    Gopalakrishna, Kadarapura N.
    Ramesh, Venkatapura J.
    JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE, 2019, 6 (01) : 160 - 166
  • [43] Guillain-Barre syndrome and hyponatraemia
    Colls, BM
    INTERNAL MEDICINE JOURNAL, 2003, 33 (1-2) : 5 - 9
  • [44] Pitfalls in Calculating the Incidence of Guillain-Barre Syndrome During the Pandemic
    Finsterer, Josef
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (02)
  • [45] Guillain-Barre Syndrome in Pregnancy
    Pacheco, Luis D.
    Saad, Antonio F.
    Hankins, Gary D. V.
    Chiosi, Giuseppe
    Saade, George
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (05): : 1105 - 1110
  • [46] Complications of Guillain-Barre syndrome
    Wang, Ying
    Zhang, Hong-Liang
    Wu, Xiujuan
    Zhu, Jie
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (04) : 439 - 448
  • [47] Guillain-Barre syndrome mimics
    Tham, Sai Leong
    Prasad, Kalpana
    Umapathi, Thirugnanam
    BRAIN AND BEHAVIOR, 2018, 8 (05):
  • [48] Familial Guillain-Barre syndrome
    Wilmshurst, JM
    Pohl, KRE
    Vaughan, RW
    Hughes, RAC
    EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (04) : 499 - 503
  • [49] Overview of Guillain-Barre Syndrome
    Amore, G.
    Spoto, G.
    Valentini, G.
    Germano, E.
    Midiri, M.
    Colavita, L.
    Concolino, D.
    Gitto, E.
    Di Rosa, G.
    Nicotera, A. G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (01): : 3 - 8
  • [50] Treatment of Guillain-Barre Syndrome
    McNair, Norma D.
    JOURNAL OF INFUSION NURSING, 2013, 36 (06) : 397 - 400